www.fdanews.com/articles/122795-tranzyme-enters-strategic-drug-discovery-collaboration-with-bms
Tranzyme Enters Strategic Drug Discovery Collaboration With BMS
December 8, 2009
Tranzyme Pharma Tuesday announced that it has entered into a strategic
collaboration agreement with Bristol-Myers Squibb Company to discover, develop and commercialize novel macrocyclic compounds directed against targets of
interest to Bristol-Myers Squibb.
Earth Times
Earth Times